PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2019 Earnings Conference Call August 6, 2019 4:30 PM ET
Company Participants
Timothy Dyer - Chief of Staff to the Chief Executive Officer
Stuart Peltz - Chief Executive Officer
Marcio Souza - Chief Operating Officer
Emily Hill - Chief Financial Officer
Conference Call Participants
Raju Prasad - William Blair
Alethia Young - Cantor Fitzgerald
Peter Kim - Barclays
Martin Auster - Credit Suisse
Vincent Chen - Bernstein
Shawn Egan - Citi
Eric Joseph - JPMorgan
Joseph Thome - Cowen & Company
Operator
Good day, ladies and gentlemen, and thank you for your patience. You've joined the PTC Therapeutics Second Quarter Corporate Updates and Financial Results Conference Call. At this time, all participants need listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference may be recorded.
I would not like to turn the call over to your host, Chief of Staff to the CEO, Timothy Dyer. Sir you may begin
Timothy Dyer
Hello. Good afternoon and thank you for joining us to discuss our 2019 second quarter corporate updates and financial results. Joining me on today's call is our CEO, Stuart Peltz; our Chief Operating Officer, Marshall Sousa; and our Chief Financial Officer, Emily Hill.
Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Please take a moment to review our slide on our simultaneous presentation, which contains our forward-looking statements.
Our actual results could materially differ from these forward-looking statements as any and such risks can materially and adversely affect our business and results of operations.
For a detailed description of applicable risks and uncertainties, we encourage you to review the company's most recent quarterly reports on Form 10-Q and annual report on Form 10-K filed with the Securities and Exchange Commission as well as the company's other SEC filings.
We will disclose certain non-GAAP information during this call. Information regarding our use of GAAP and non-GAAP financial measures and a reconciliation of GAAP to non-GAAP is available for today's earnings release.
With that, let me pass the call over to our CEO, Stuart Peltz.
